Major Depressive Disorder and Axis I Diagnostic Comorbidity
The DOI matches its Crossref record.
Abstract
BACKGROUND: Recognition of comorbid conditions in patients presenting for the treatment of depression is clinically important because the presence of other disorders can influence treatment planning. In the present study, we examined the frequency of diagnostic comorbidity in psychiatric outpatients presenting for treatment of nonbipolar major depressive disorder (MDD) and patients' desire for treatment for the comorbid disorders. METHOD: Four hundred seventy-nine psychiatric outpatients with DSM-IV nonbipolar MDD were evaluated with a modified version of the Structured Clinical Interview for DSM-IV. RESULTS: Excluding nicotine dependence, at the time of the evaluation 64.1% (N = 307) of the patients met criteria for at least 1 of the 23 specific Axis I disorders, and more than one third (36.7%, N = 176) had 2 or more disorders. Anxiety disorders, as a group, were the most frequent current comorbid disorders (56.8%), and social phobia was the most frequent individual disorder. Including subthreshold conditions, the percentage of patients with at least 1 disorder increased to 73.5%. When the scope of assessment was expanded to include nicotine dependence, nicotine dependence was the most frequent lifetime individual disorder (38.2%) and the second most frequent current disorder (27.3%). There was considerable variability among the disorders regarding desire for treatment of the comorbid condition. CONCLUSION: The majority of nonbipolar depressed patients have a current comorbid disorder, especially an anxiety disorder, although the actual rate of comorbidity depends on the breadth of the assessment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The STAR * D trial [40] was based on adaptive interventions that followed non-response to initial treatment, such as switching to or augmentation with another type of treatment, potentially modifying treatment response.”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [40]
In the citing paper
“This means that the strenuous efforts after step 1 (open treatment with citalopram) yielded an additional 6% of sustained recovery.”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [40]
In the citing paper
“Further, intolerance (dropouts for any reason during the first 4 weeks or side effects afterwards) increased after each treatment step.”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [40]
In the citing paper
“Rates of relapse increased after each treatment step in patients who achieved remission.”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [40]
In the citing paper
“The cumulative rate of remission after 4 sequential steps was 67% and, when sustained recovery (taking into account relapse rates while under treatment) was considered, the cumulative rate was 43%.”
From The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem (2020) · cites this paper as [40]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Still being checked.
Cited by
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Major depression and comorbid substance use disorders
Davis, L., Uezato, A., Newell, J. M., & Frazier, E. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e3282f32408 · Cited by 498
The prevalence and impact of alcohol problems in major depression: A systematic review
Sullivan, L. E., Fiellin, D. A., & O’Connor, P. G. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.01.007 · Cited by 489
Kessler, R. C., Merikangas, K. R., & Wang, P. S. (2007) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.3.022806.091444 · Cited by 468
Metadata
- Authors
- Zimmerman, M., Chelminski, I., & McDermut, W.
- Affiliations
- Brown University (US)
- William Paterson University (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2002-03-15
- Volume
- 63
- Issue
- 3
- Pages
- 187-193
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2007367045
- Cited by
- 158
- References
- 0
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 4 · 2023: 4 · 2021: 6 · 2020: 6 · 2019: 3 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 9 · 2013: 13 · 2012: 14
- FWCI
- 11.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-56404)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, Axis I disorders, psychiatric outpatients, anxiety disorders, social anxiety disorder, nicotine dependence, comorbidity assessment
- MeSH terms
- Adult, Aged, Anxiety Disorders, Feeding and Eating Disorders, Major Depressive Disorder, Female, Humans, Disruptive, Impulse Control, and Conduct Disorders, Male, Middle Aged, Somatoform Disorders, United States, Comorbidity, Prevalence, Mood Disorders, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Major Depressive Disorder and Axis I Diagnostic Comorbidity. https://app.cochat.ai/papers/10.4088/jcp.v63n0303
- The paper
- Zimmerman, M., Chelminski, I., & McDermut, W. (2002). Major Depressive Disorder and Axis I Diagnostic Comorbidity. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v63n0303
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.